Today is the second day of psychedelics @NIH ๐Ÿ‡บ๐Ÿ‡ฒ with a critical issue to be tackled:

What is a #controlled study with psychedelics?

How to do it?

Why is it important?
Starting now with Michael Bogenschutz from @nyuniversity discussing what was left in the background yesterday: subjective effects
Mixed correlation results between MEQ subjective ratings and therapeutic outcomes for alcohol abuse ๐Ÿค”
What now?

Is it all in the ๐Ÿง ?
Now Jennifer Mitchell from @UCSF, first author of landmark Phase 3 MDMA for PTSD study out last year @NatureMedicine
Current PTSD standard of care

Drug OR psychotherapy?
New model

Drug AND therapy?
In 2018 I explained why the new model can constitute a new paradigm frontiersin.org/articles/10.33โ€ฆ
The essence of MDMA therapy

๐Ÿ’”Love?โค๏ธ
Useful method for double-blinding? ๐Ÿ™ˆ

Necessary? Sufficient?
SAEs, clearly higher in placebo arm

What about clinical equipoise and ethics for further trials?
Efficacy ๐Ÿ‘๐Ÿ‘๐Ÿ‘๐Ÿ‘๐Ÿ‘
Now @Drug_Researcher from @JHPsychedelics who's doing this for about 2 decades ๐Ÿ’ช mostly with #psilocybin
Is this even safe?

We can ask the ๐Ÿ‡ฒ๐Ÿ‡ฝMazatec๐ŸŒต as well
๐Ÿ‡บ๐Ÿ‡ฒDrug fatalities

๐Ÿพ๐Ÿท๐Ÿบ๐Ÿšฌ๐Ÿ“ˆ
Turn on, tune in, drop cigarettes? ๐Ÿšญ
Now @profceliamorgan from @UniofExeter ๐Ÿ‡ฌ๐Ÿ‡ง on Ketamine for alcohol ๐Ÿบ๐Ÿท๐Ÿพabuse
Therapeutic effect?

Adverse effect?

Epiphenomena?
Important considerations ๐Ÿง
Now my dear friend and mentor Michael Mithoefer on his groundbreaking decades of work with MDMA therapy with @MAPS and @MAPSPBC
Blinding ๐Ÿ™ˆchallenges ๐Ÿ™Š
Low dose, a solution? ๐Ÿค”
Other comparators...
Phase 3 unblinding
Recent challenge at @NatureMedicine by @MattBurkeMD
Now discussant Elias Dakwar questioning the (in)famous P name(s)
Many models...

Watch out for epistemic injustices with those ""
What's going on?
What's behind RCTs?
What can be lost?
Paradigm shift?

YES ๐Ÿ‘
Ethics for new medicines.

Awesome discussion ๐Ÿ‘๐Ÿ’ช๐Ÿ‘๐Ÿ‘๐Ÿ‘
Western culturally biased constructs
๐Ÿงจ
Another great panel, and a trully remarkable event!!! facing hard issues up-front ๐Ÿ’ช
Unblinding and controls clearly a difficult question.

Do we have a methodological problem, or do we have a philosophical issue?

tandfonline.com/doi/full/10.10โ€ฆ
@threadreaderapp compile please

โ€ข โ€ข โ€ข

Missing some Tweet in this thread? You can try to force a refresh
ใ€€

Keep Current with Eduardo Schenberg, PhD

Eduardo Schenberg, PhD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ee_schenberg

14 Jan
This week #psychedelics, almost completely ignored by western science and medicine in the last quarter of the 20th century, made it to the top of ๐Ÿ‡บ๐Ÿ‡ธ healthcare, the @NIH:

4k folks ๐ŸŒ 21 time zones
+10h of talks
Panelists from
๐Ÿ‡บ๐Ÿ‡ธ 12
๐Ÿ‡จ๐Ÿ‡ฆ 1
๐Ÿ‡ฎ๐Ÿ‡ฑ 1
๐Ÿ‡ฉ๐Ÿ‡ฐ 1
๐Ÿ‡ฌ๐Ÿ‡ง 1
๐Ÿ‡ณ๐Ÿ‡ฟ 1
๐Ÿ‡จ๐Ÿ‡ญ 1

๐Ÿงต summary ๐Ÿ‘‡
Agenda comprised 3 main themes:
Basic and translational research ๐Ÿ€๐Ÿ”ฌ๐Ÿ‘ฉโ€๐Ÿ”ฌ๐Ÿ‘จโ€๐Ÿ”ฌ๐Ÿงฎ๐Ÿ’ป
Clinical trials ๐Ÿ‘ฉโ€โš•๏ธ๐Ÿง‘โ€โš•๏ธ๐Ÿ‘จโ€โš•๏ธ๐Ÿคฎ๐Ÿ’Š๐Ÿค’๐Ÿ’‰
Optimising future trial designs ๐Ÿ’พ๐Ÿ’ฝ๐Ÿ’ฟ๐Ÿ“€
Here are my remarks from 20y experience:
This is a good landmark to claim psychedelic science finally achieved maturity
Basic research is evolving rapidly and public funding ๐Ÿ’ฐis what is needed to transform the field
Clinical trials suggest transdiagnostic safety and efficacy
Read 5 tweets
13 Jan
Third and last session of #psychedelics @NIH ๐Ÿ‡บ๐Ÿ‡ฒ workshop starting now, looking at how to optimize clinical trials design and how to get these treatments approved ๐Ÿงต
Starting with Ido @hartogsohn ๐Ÿ‡ฎ๐Ÿ‡ฑ on psychedelic set and setting theory
Important Q โ“

Do we have an (excessively) costly and complicated drug regulation apparatus?
Read 19 tweets
12 Jan
Psychedelics making it today to the top of USA ๐Ÿ‡บ๐Ÿ‡ฒ health institutions: @NIH
Joshua Gordon started emphasizing NIH's #mechanistic funding focus
4k attendees in 21 time zones ๐ŸŒ๐ŸŒŽ๐ŸŒ
Read 30 tweets
8 Oct 21
researchgate.net/publication/35โ€ฆ

Overcoming #EpistemicInjustices in the biomedical study of #ayahuasca: Towards #ethical and sustainable #regulation. New paper for โ€œCultural context and ethical issues in the therapeutic use of psychedelicsโ€ special issue of Transcultural Psychiatry ๐Ÿงต1/
We (me and non-tweeter ๐Ÿ‡ง๐Ÿ‡ท PhD lawyer Konstantin Gerber) reviewed 4 decades of biomedical research about the sacred and ancient vine of the Amazon, documenting how biomedicine systematically commits a specific kind of injustice: against indigenous people as givers of knowledge. 2/
The powerful concept of epistemic injustice was introduced 15 years ago by Miranda Fricker (University of Oxford) and greatly helped us frame and analyse some past and current trends in ayahuasca research, which is also important to psychedelic science in general. 3/ Image
Read 17 tweets
5 Jul 21
1/16 THREAD๐Ÿงต3 years ago I proposed that #Psychedelic-Assisted Psychotherapy (PAP) is a #ParadigmShift in psychiatry. The paper has been viewed almost 80k times around the globe and sits at the top 1% views/downloads and top 8% citations of the whole @FrontiersIn journal series.
2/16 Published in the special issue โ€œPsychedelic Drug Research in the 21st Centuryโ€ it has 82 citations at Google Scholar and was included in one slide by Javier Muรฑiz, from the FDAโ€™s division of psychiatry, at his ISRP lecture in Oct/2019 frontiersin.org/articles/10.33โ€ฆ
3/16 My perspective on the psychedelic impact on psychiatric research and development was based on Prof. @rose_nikolas useful critique of the current situation in psychiatry as a triple crisis
cambridge.org/core/journals/โ€ฆ
Read 16 tweets
15 Mar 21
1/18 This tweet completes two months today (and our paper 74 days). What happened since? [a non exhaustive psychedelic patenting thread]
2/18 We got close to 6k views (approx 80/day) Image
3/18 Brazilian journalist @MarceloNLeite published a post in his blog, thanks Marcelo!
bit.ly/3qHKIAo
Read 20 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(